Lilly Breaks Ground on $3.5-Bn Injectables Mfg Site in US 
By

By
Eli Lilly and Company has broken ground on a $3.5-billion manufacturing facility in Fogelsville in the Lehigh Valley, Pennsylvania, which will produce injectable medicines and devices. The new facility is…

BASF Calls Off Bid for Evonik 
By

By
BASF has announced that it will end its efforts to acquire Evonik Industries AG, a producer of specialty and fine chemicals. The decision follows Evonik’s rejection of two non-binding all-cash…

Isomorphic Labs Raises $5 Bn To Support AI-Based Drug Design 
By

By
Isomorphic Labs, an AI-enabled drug design and development company, has raised $5 billion to support the continued development and deployment of its AI-enabled proprietary drug design engine, IsoDDE, used to…

J&J To Acquire Ollin Biosciences for $2.2 Bn 
By

By
Johnson & Johnson (J&J) has agreed to acquire Ollin Biosciences, a clinical-stage bio/pharmaceutical company focused on therapies for serious eye diseases, in a deal worth up to $3.3 billion ($2.2…

Supplier News: Lotte Biologics, Thermo Fisher Scientific, Evonik, Aptar Pharma & ACG 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lotte Biologics, Thermo Fisher Scientific, Evonik, Aptar Pharma, and ACG.   Biologics Manufacturing * Lotte Biologics Opens New Bio Campus, Signs Mfg Agreement * Thermo…

Global Briefs: Shionogi, Lilly, Pfizer, Sanofi, Merck & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Shionogi, Eli Lilly and Company, Pfizer, AbbVie, Sanofi, Biogen, Vertex Pharmaceuticals, Merck, Novo, BeOne Medicines, and Gilead Sciences.…

Biotech Briefs: Innogen Pharmaceuticals, Arcera, Windward Bio, Marrow Therapeutics & GeneDx 
By

By
The latest from small and Emerging Pharma companies featuring Innogen Pharmaceuticals,  Arcera Life Sciences, Windward Bio, Marrow Therapeutics and GeneDx.  For news on the large and mid-sized bio/pharmaceutical companies, see…

Pfizer Gains $1.5 Bn in Funding from Blackstone for Obesity Drug 
By

By
Pfizer and Blackstone Life Sciences, a private investment platform focused on the bio/pharmaceutical and life sciences sector, of the private equity firm, Blackstone, have announced a strategic co-funding agreement under…

Simtra BioPharma Solutions Opens $250-M Injectables Mfg Expansion 
By

By
Simtra BioPharma Solutions, a CDMO specializing in injectable medicines, has opened a more than $250-million expansion of its Bloomington, Indiana, manufacturing campus. The 153,000-square-foot building adds new prefilled syringe, vial,…

US Gov’t Codifies Medicare Drug Price Negotiation Program 
By

By
The US Centers for Medicare & Medicaid Services (CMS) has issued a final rule that codifies policies established in guidance documents for the Medicare Drug Price Negotiation Program for initial…